Rosacea – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Rosacea – Drugs In Development, 2024 report and make more profitable business decisions.
Rosacea is a chronic and potentially life-disruptive disorder primarily of the facial skin, often characterized by flare-ups and remissions. Symptoms include frequent redness of the face, or flushing; small red lines under the skin; a swollen nose; and thick skin, usually on the forehead, chin, and cheeks. The predisposing factors include age and family history of rosacea. Treatment includes antibiotics and acne drugs.
The Rosacea drugs in development market research report provide comprehensive information on the therapeutics under development for Rosacea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Rosacea and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Rosacea | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 21 molecules, with 21 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Rosacea therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Rosacea pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Rosacea treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Accuitis Pharmaceuticals IncAlfasigma SpA
Amgen Inc
Amytrx Therapeutics Inc
AOBiome LLC
Arctic Therapeutics ehf
Arcutis Biotherapeutics Inc
Attillaps Holdings Inc
Botanix Pharmaceuticals Ltd
Maruho Co Ltd
Matrisys Bioscience Inc
NanoPharmaceuticals LLC
Perpetuum BV
Pfizer Inc
Promius Pharma LLC
Retinoids JSC
Sunny Pharmtech Inc
Tarsus Pharmaceuticals Inc
Teva Pharmaceutical Industries Ltd
Timber Pharmaceuticals Inc
TWi Biotechnology Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Rosacea reports